nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Topotecan—ovarian cancer	0.229	0.531	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Epirubicin—ovarian cancer	0.105	0.244	CiPCiCtD
Etoposide—uterine cancer—ovarian cancer	0.1	0.407	CtDrD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—ovarian cancer	0.0974	0.225	CiPCiCtD
Etoposide—testicular cancer—ovarian cancer	0.0748	0.303	CtDrD
Etoposide—germ cell cancer—ovarian cancer	0.0716	0.29	CtDrD
Etoposide—GSTP1—Chlorambucil—ovarian cancer	0.0504	0.247	CbGbCtD
Etoposide—ABCB1—ovarian cancer	0.0354	1	CbGaD
Etoposide—GSTT1—Carboplatin—ovarian cancer	0.0261	0.128	CbGbCtD
Etoposide—GSTP1—Carboplatin—ovarian cancer	0.0163	0.0798	CbGbCtD
Etoposide—ABCC10—Paclitaxel—ovarian cancer	0.0122	0.0596	CbGbCtD
Etoposide—ABCC10—Docetaxel—ovarian cancer	0.00879	0.0431	CbGbCtD
Etoposide—TOP2A—Epirubicin—ovarian cancer	0.00858	0.0421	CbGbCtD
Etoposide—ABCC6—Doxorubicin—ovarian cancer	0.00857	0.042	CbGbCtD
Etoposide—ABCC10—Doxorubicin—ovarian cancer	0.00655	0.0321	CbGbCtD
Etoposide—ABCG2—Topotecan—ovarian cancer	0.00634	0.0311	CbGbCtD
Etoposide—ABCC1—Epirubicin—ovarian cancer	0.00476	0.0233	CbGbCtD
Etoposide—ABCC1—Paclitaxel—ovarian cancer	0.00469	0.023	CbGbCtD
Etoposide—TOP2A—Doxorubicin—ovarian cancer	0.00456	0.0224	CbGbCtD
Etoposide—ABCC3—Doxorubicin—ovarian cancer	0.00412	0.0202	CbGbCtD
Etoposide—ABCC2—Paclitaxel—ovarian cancer	0.00347	0.017	CbGbCtD
Etoposide—ABCC1—Docetaxel—ovarian cancer	0.00339	0.0166	CbGbCtD
Etoposide—ABCC2—Carboplatin—ovarian cancer	0.00327	0.016	CbGbCtD
Etoposide—ABCG2—Paclitaxel—ovarian cancer	0.00314	0.0154	CbGbCtD
Etoposide—ABCG2—Carboplatin—ovarian cancer	0.00295	0.0145	CbGbCtD
Etoposide—ABCC1—Doxorubicin—ovarian cancer	0.00253	0.0124	CbGbCtD
Etoposide—ABCC2—Docetaxel—ovarian cancer	0.00251	0.0123	CbGbCtD
Etoposide—ABCB1—Topotecan—ovarian cancer	0.00229	0.0112	CbGbCtD
Etoposide—ABCG2—Docetaxel—ovarian cancer	0.00227	0.0111	CbGbCtD
Etoposide—ABCC2—Doxorubicin—ovarian cancer	0.00187	0.00918	CbGbCtD
Etoposide—CYP3A5—Paclitaxel—ovarian cancer	0.00174	0.00853	CbGbCtD
Etoposide—ABCG2—Doxorubicin—ovarian cancer	0.00169	0.0083	CbGbCtD
Etoposide—CYP2C8—Paclitaxel—ovarian cancer	0.00167	0.0082	CbGbCtD
Etoposide—ABCB1—Vinorelbine—ovarian cancer	0.00161	0.0079	CbGbCtD
Etoposide—CYP3A4—Topotecan—ovarian cancer	0.00137	0.00672	CbGbCtD
Etoposide—CYP3A5—Docetaxel—ovarian cancer	0.00126	0.00617	CbGbCtD
Etoposide—ABCB1—Paclitaxel—ovarian cancer	0.00113	0.00555	CbGbCtD
Etoposide—CYP3A4—Vinorelbine—ovarian cancer	0.000965	0.00473	CbGbCtD
Etoposide—PTGS2—ovarian follicle—ovarian cancer	0.000837	0.0471	CbGeAlD
Etoposide—ABCB1—Docetaxel—ovarian cancer	0.000818	0.00401	CbGbCtD
Etoposide—GSTP1—oviduct—ovarian cancer	0.000789	0.0444	CbGeAlD
Etoposide—CYP3A4—Paclitaxel—ovarian cancer	0.000678	0.00333	CbGbCtD
Etoposide—ABCB1—Doxorubicin—ovarian cancer	0.00061	0.00299	CbGbCtD
Etoposide—CYP3A4—Docetaxel—ovarian cancer	0.00049	0.0024	CbGbCtD
Etoposide—TOP2B—myometrium—ovarian cancer	0.000403	0.0227	CbGeAlD
Etoposide—TOP2B—embryo—ovarian cancer	0.000388	0.0218	CbGeAlD
Etoposide—PTGS1—oviduct—ovarian cancer	0.000385	0.0217	CbGeAlD
Etoposide—CYP3A4—Doxorubicin—ovarian cancer	0.000366	0.00179	CbGbCtD
Etoposide—GSTT1—female reproductive system—ovarian cancer	0.000319	0.0179	CbGeAlD
Etoposide—TOP2B—uterine cervix—ovarian cancer	0.000314	0.0176	CbGeAlD
Etoposide—TOP2B—decidua—ovarian cancer	0.000299	0.0168	CbGeAlD
Etoposide—TOP2A—myometrium—ovarian cancer	0.000296	0.0167	CbGeAlD
Etoposide—TOP2B—endometrium—ovarian cancer	0.000284	0.016	CbGeAlD
Etoposide—TOP2B—gonad—ovarian cancer	0.000263	0.0148	CbGeAlD
Etoposide—TOP2B—uterus—ovarian cancer	0.000261	0.0147	CbGeAlD
Etoposide—GSTP1—myometrium—ovarian cancer	0.000252	0.0142	CbGeAlD
Etoposide—ABCC10—myometrium—ovarian cancer	0.000252	0.0142	CbGeAlD
Etoposide—GSTP1—embryo—ovarian cancer	0.000243	0.0137	CbGeAlD
Etoposide—TOP2B—female reproductive system—ovarian cancer	0.000235	0.0132	CbGeAlD
Etoposide—TOP2A—uterine cervix—ovarian cancer	0.000231	0.013	CbGeAlD
Etoposide—TOP2B—bone marrow—ovarian cancer	0.000222	0.0125	CbGeAlD
Etoposide—TOP2A—decidua—ovarian cancer	0.00022	0.0124	CbGeAlD
Etoposide—TOP2B—female gonad—ovarian cancer	0.000214	0.012	CbGeAlD
Etoposide—TOP2B—vagina—ovarian cancer	0.000212	0.012	CbGeAlD
Etoposide—TOP2A—endometrium—ovarian cancer	0.000209	0.0117	CbGeAlD
Etoposide—GSTP1—epithelium—ovarian cancer	0.000198	0.0111	CbGeAlD
Etoposide—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.000196	0.219	CbGdCrCtD
Etoposide—GSTP1—uterine cervix—ovarian cancer	0.000196	0.0111	CbGeAlD
Etoposide—ABCC10—uterine cervix—ovarian cancer	0.000196	0.011	CbGeAlD
Etoposide—TOP2A—uterus—ovarian cancer	0.000192	0.0108	CbGeAlD
Etoposide—TOP2B—testis—ovarian cancer	0.00019	0.0107	CbGeAlD
Etoposide—ABCC3—decidua—ovarian cancer	0.000188	0.0106	CbGeAlD
Etoposide—GSTP1—decidua—ovarian cancer	0.000187	0.0105	CbGeAlD
Etoposide—ABCC10—decidua—ovarian cancer	0.000187	0.0105	CbGeAlD
Etoposide—ABCC1—myometrium—ovarian cancer	0.000178	0.01	CbGeAlD
Etoposide—GSTP1—endometrium—ovarian cancer	0.000178	0.01	CbGeAlD
Etoposide—ABCC10—endometrium—ovarian cancer	0.000178	0.00999	CbGeAlD
Etoposide—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.000168	0.187	CbGdCrCtD
Etoposide—GSTP1—gonad—ovarian cancer	0.000165	0.00927	CbGeAlD
Etoposide—ABCC10—gonad—ovarian cancer	0.000165	0.00927	CbGeAlD
Etoposide—GSTP1—uterus—ovarian cancer	0.000164	0.00921	CbGeAlD
Etoposide—ABCC10—uterus—ovarian cancer	0.000164	0.00921	CbGeAlD
Etoposide—TOP2A—bone marrow—ovarian cancer	0.000163	0.00918	CbGeAlD
Etoposide—TOP2A—female gonad—ovarian cancer	0.000157	0.00885	CbGeAlD
Etoposide—TOP2A—vagina—ovarian cancer	0.000156	0.00879	CbGeAlD
Etoposide—ABCC3—female reproductive system—ovarian cancer	0.000148	0.00832	CbGeAlD
Etoposide—ABCG2—myometrium—ovarian cancer	0.000148	0.00831	CbGeAlD
Etoposide—GSTP1—female reproductive system—ovarian cancer	0.000147	0.00828	CbGeAlD
Etoposide—ABCC10—female reproductive system—ovarian cancer	0.000147	0.00828	CbGeAlD
Etoposide—TOP2A—testis—ovarian cancer	0.000139	0.00785	CbGeAlD
Etoposide—GSTP1—bone marrow—ovarian cancer	0.000139	0.00782	CbGeAlD
Etoposide—ABCC10—bone marrow—ovarian cancer	0.000139	0.00781	CbGeAlD
Etoposide—ABCC1—uterine cervix—ovarian cancer	0.000139	0.00781	CbGeAlD
Etoposide—TOP2B—lymph node—ovarian cancer	0.000137	0.00773	CbGeAlD
Etoposide—ABCC3—female gonad—ovarian cancer	0.000134	0.00757	CbGeAlD
Etoposide—GSTP1—female gonad—ovarian cancer	0.000134	0.00754	CbGeAlD
Etoposide—ABCC10—female gonad—ovarian cancer	0.000134	0.00753	CbGeAlD
Etoposide—GSTP1—vagina—ovarian cancer	0.000133	0.00749	CbGeAlD
Etoposide—ABCC10—vagina—ovarian cancer	0.000133	0.00749	CbGeAlD
Etoposide—ABCC1—decidua—ovarian cancer	0.000132	0.00744	CbGeAlD
Etoposide—ABCC1—endometrium—ovarian cancer	0.000126	0.00707	CbGeAlD
Etoposide—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.000125	0.139	CbGdCrCtD
Etoposide—ABCC3—testis—ovarian cancer	0.000119	0.00671	CbGeAlD
Etoposide—GSTP1—testis—ovarian cancer	0.000119	0.00668	CbGeAlD
Etoposide—ABCC10—testis—ovarian cancer	0.000119	0.00668	CbGeAlD
Etoposide—ABCC2—female reproductive system—ovarian cancer	0.000118	0.00665	CbGeAlD
Etoposide—PTGS2—myometrium—ovarian cancer	0.000118	0.00663	CbGeAlD
Etoposide—ABCC1—uterus—ovarian cancer	0.000116	0.00651	CbGeAlD
Etoposide—ABCG2—uterine cervix—ovarian cancer	0.000115	0.00647	CbGeAlD
Etoposide—PTGS2—embryo—ovarian cancer	0.000113	0.00637	CbGeAlD
Etoposide—ABCG2—decidua—ovarian cancer	0.000109	0.00616	CbGeAlD
Etoposide—CYP2C8—endometrium—ovarian cancer	0.000107	0.00602	CbGeAlD
Etoposide—CYP3A5—uterine cervix—ovarian cancer	0.000107	0.006	CbGeAlD
Etoposide—ABCG2—endometrium—ovarian cancer	0.000104	0.00585	CbGeAlD
Etoposide—TOP2A—lymph node—ovarian cancer	0.000101	0.00569	CbGeAlD
Etoposide—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	9.81e-05	0.109	CbGdCrCtD
Etoposide—PTGS1—epithelium—ovarian cancer	9.67e-05	0.00544	CbGeAlD
Etoposide—PTGS1—uterine cervix—ovarian cancer	9.59e-05	0.00539	CbGeAlD
Etoposide—ABCG2—uterus—ovarian cancer	9.58e-05	0.00539	CbGeAlD
Etoposide—ABCC2—testis—ovarian cancer	9.53e-05	0.00536	CbGeAlD
Etoposide—ABCC1—female gonad—ovarian cancer	9.46e-05	0.00533	CbGeAlD
Etoposide—ABCC1—vagina—ovarian cancer	9.41e-05	0.00529	CbGeAlD
Etoposide—PTGS2—epithelium—ovarian cancer	9.24e-05	0.0052	CbGeAlD
Etoposide—PTGS2—uterine cervix—ovarian cancer	9.16e-05	0.00516	CbGeAlD
Etoposide—CYP2C8—female reproductive system—ovarian cancer	8.86e-05	0.00498	CbGeAlD
Etoposide—PTGS1—endometrium—ovarian cancer	8.67e-05	0.00488	CbGeAlD
Etoposide—ABCC3—lymph node—ovarian cancer	8.64e-05	0.00487	CbGeAlD
Etoposide—GSTP1—lymph node—ovarian cancer	8.61e-05	0.00484	CbGeAlD
Etoposide—ABCC10—lymph node—ovarian cancer	8.6e-05	0.00484	CbGeAlD
Etoposide—ABCC1—testis—ovarian cancer	8.39e-05	0.00472	CbGeAlD
Etoposide—PTGS2—endometrium—ovarian cancer	8.29e-05	0.00466	CbGeAlD
Etoposide—ABCG2—bone marrow—ovarian cancer	8.13e-05	0.00458	CbGeAlD
Etoposide—CYP2C8—vagina—ovarian cancer	8.01e-05	0.00451	CbGeAlD
Etoposide—PTGS1—uterus—ovarian cancer	7.99e-05	0.0045	CbGeAlD
Etoposide—ABCG2—female gonad—ovarian cancer	7.84e-05	0.00441	CbGeAlD
Etoposide—ABCG2—vagina—ovarian cancer	7.79e-05	0.00438	CbGeAlD
Etoposide—PTGS2—uterus—ovarian cancer	7.64e-05	0.0043	CbGeAlD
Etoposide—CYP2E1—female reproductive system—ovarian cancer	7.46e-05	0.0042	CbGeAlD
Etoposide—ABCB1—myometrium—ovarian cancer	7.28e-05	0.0041	CbGeAlD
Etoposide—CYP3A5—female gonad—ovarian cancer	7.27e-05	0.00409	CbGeAlD
Etoposide—CYP3A5—vagina—ovarian cancer	7.23e-05	0.00407	CbGeAlD
Etoposide—PTGS1—female reproductive system—ovarian cancer	7.18e-05	0.00404	CbGeAlD
Etoposide—CYP2C8—testis—ovarian cancer	7.15e-05	0.00402	CbGeAlD
Etoposide—ABCB1—embryo—ovarian cancer	7e-05	0.00394	CbGeAlD
Etoposide—ABCG2—testis—ovarian cancer	6.95e-05	0.00391	CbGeAlD
Etoposide—ABCC2—lymph node—ovarian cancer	6.91e-05	0.00389	CbGeAlD
Etoposide—PTGS2—female reproductive system—ovarian cancer	6.86e-05	0.00386	CbGeAlD
Etoposide—TOP2A—Vincristine—Vinorelbine—ovarian cancer	6.74e-05	0.075	CbGdCrCtD
Etoposide—PTGS1—female gonad—ovarian cancer	6.53e-05	0.00368	CbGeAlD
Etoposide—PTGS1—vagina—ovarian cancer	6.5e-05	0.00366	CbGeAlD
Etoposide—PTGS2—bone marrow—ovarian cancer	6.48e-05	0.00365	CbGeAlD
Etoposide—PTGS2—female gonad—ovarian cancer	6.25e-05	0.00352	CbGeAlD
Etoposide—PTGS2—vagina—ovarian cancer	6.21e-05	0.00349	CbGeAlD
Etoposide—ABCC1—lymph node—ovarian cancer	6.08e-05	0.00342	CbGeAlD
Etoposide—CYP2E1—testis—ovarian cancer	6.02e-05	0.00339	CbGeAlD
Etoposide—CYP3A4—female reproductive system—ovarian cancer	6e-05	0.00338	CbGeAlD
Etoposide—PTGS1—testis—ovarian cancer	5.8e-05	0.00326	CbGeAlD
Etoposide—ABCB1—epithelium—ovarian cancer	5.72e-05	0.00322	CbGeAlD
Etoposide—ABCB1—uterine cervix—ovarian cancer	5.67e-05	0.00319	CbGeAlD
Etoposide—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	5.42e-05	0.0603	CbGdCrCtD
Etoposide—ABCB1—decidua—ovarian cancer	5.4e-05	0.00304	CbGeAlD
Etoposide—ABCB1—endometrium—ovarian cancer	5.13e-05	0.00288	CbGeAlD
Etoposide—ABCG2—lymph node—ovarian cancer	5.04e-05	0.00283	CbGeAlD
Etoposide—ABCB1—gonad—ovarian cancer	4.75e-05	0.00268	CbGeAlD
Etoposide—ABCB1—uterus—ovarian cancer	4.72e-05	0.00266	CbGeAlD
Etoposide—ABCB1—female reproductive system—ovarian cancer	4.25e-05	0.00239	CbGeAlD
Etoposide—PTGS1—lymph node—ovarian cancer	4.2e-05	0.00236	CbGeAlD
Etoposide—PTGS2—lymph node—ovarian cancer	4.02e-05	0.00226	CbGeAlD
Etoposide—ABCB1—bone marrow—ovarian cancer	4.01e-05	0.00226	CbGeAlD
Etoposide—ABCB1—female gonad—ovarian cancer	3.86e-05	0.00217	CbGeAlD
Etoposide—ABCB1—vagina—ovarian cancer	3.84e-05	0.00216	CbGeAlD
Etoposide—ABCB1—testis—ovarian cancer	3.43e-05	0.00193	CbGeAlD
Etoposide—TOP2A—Idarubicin—Epirubicin—ovarian cancer	3.28e-05	0.0365	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	3.28e-05	0.0365	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	3.28e-05	0.0365	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	3.04e-05	0.0338	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	3.04e-05	0.0338	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	3.04e-05	0.0338	CbGdCrCtD
Etoposide—Dermatitis—Topotecan—ovarian cancer	2.75e-05	0.000541	CcSEcCtD
Etoposide—Headache—Topotecan—ovarian cancer	2.74e-05	0.000538	CcSEcCtD
Etoposide—Angiopathy—Docetaxel—ovarian cancer	2.72e-05	0.000535	CcSEcCtD
Etoposide—Vomiting—Melphalan—ovarian cancer	2.72e-05	0.000535	CcSEcCtD
Etoposide—Immune system disorder—Docetaxel—ovarian cancer	2.71e-05	0.000533	CcSEcCtD
Etoposide—Loss of consciousness—Paclitaxel—ovarian cancer	2.71e-05	0.000532	CcSEcCtD
Etoposide—Mediastinal disorder—Docetaxel—ovarian cancer	2.71e-05	0.000531	CcSEcCtD
Etoposide—Rash—Melphalan—ovarian cancer	2.7e-05	0.00053	CcSEcCtD
Etoposide—Dermatitis—Melphalan—ovarian cancer	2.7e-05	0.00053	CcSEcCtD
Etoposide—Chills—Docetaxel—ovarian cancer	2.69e-05	0.000529	CcSEcCtD
Etoposide—Cough—Paclitaxel—ovarian cancer	2.69e-05	0.000528	CcSEcCtD
Etoposide—Asthenia—Vinorelbine—ovarian cancer	2.68e-05	0.000527	CcSEcCtD
Etoposide—Convulsion—Paclitaxel—ovarian cancer	2.67e-05	0.000525	CcSEcCtD
Etoposide—Hypertension—Paclitaxel—ovarian cancer	2.66e-05	0.000523	CcSEcCtD
Etoposide—Alopecia—Docetaxel—ovarian cancer	2.65e-05	0.000521	CcSEcCtD
Etoposide—Pruritus—Vinorelbine—ovarian cancer	2.65e-05	0.00052	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	2.64e-05	0.000518	CcSEcCtD
Etoposide—Chest pain—Paclitaxel—ovarian cancer	2.62e-05	0.000516	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	2.61e-05	0.000512	CcSEcCtD
Etoposide—Nausea—Topotecan—ovarian cancer	2.6e-05	0.00051	CcSEcCtD
Etoposide—Discomfort—Paclitaxel—ovarian cancer	2.59e-05	0.000509	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Epirubicin—ovarian cancer	2.58e-05	0.000507	CcSEcCtD
Etoposide—Cardiac arrest—Doxorubicin—ovarian cancer	2.58e-05	0.000506	CcSEcCtD
Etoposide—Diarrhoea—Vinorelbine—ovarian cancer	2.56e-05	0.000503	CcSEcCtD
Etoposide—Dysgeusia—Docetaxel—ovarian cancer	2.56e-05	0.000503	CcSEcCtD
Etoposide—Nausea—Melphalan—ovarian cancer	2.54e-05	0.0005	CcSEcCtD
Etoposide—Confusional state—Paclitaxel—ovarian cancer	2.54e-05	0.000498	CcSEcCtD
Etoposide—Dysphagia—Epirubicin—ovarian cancer	2.53e-05	0.000497	CcSEcCtD
Etoposide—Back pain—Docetaxel—ovarian cancer	2.53e-05	0.000497	CcSEcCtD
Etoposide—Anaphylactic shock—Paclitaxel—ovarian cancer	2.52e-05	0.000494	CcSEcCtD
Etoposide—Muscle spasms—Docetaxel—ovarian cancer	2.51e-05	0.000494	CcSEcCtD
Etoposide—Infection—Paclitaxel—ovarian cancer	2.5e-05	0.000491	CcSEcCtD
Etoposide—ABCB1—lymph node—ovarian cancer	2.48e-05	0.0014	CbGeAlD
Etoposide—Dizziness—Vinorelbine—ovarian cancer	2.47e-05	0.000486	CcSEcCtD
Etoposide—Thrombocytopenia—Paclitaxel—ovarian cancer	2.46e-05	0.000484	CcSEcCtD
Etoposide—Tachycardia—Paclitaxel—ovarian cancer	2.46e-05	0.000482	CcSEcCtD
Etoposide—Skin disorder—Paclitaxel—ovarian cancer	2.44e-05	0.00048	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	2.44e-05	0.000479	CcSEcCtD
Etoposide—Hyperhidrosis—Paclitaxel—ovarian cancer	2.43e-05	0.000478	CcSEcCtD
Etoposide—Anaemia—Docetaxel—ovarian cancer	2.42e-05	0.000474	CcSEcCtD
Etoposide—Pancytopenia—Epirubicin—ovarian cancer	2.4e-05	0.000472	CcSEcCtD
Etoposide—Anorexia—Paclitaxel—ovarian cancer	2.4e-05	0.000471	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	2.39e-05	0.000469	CcSEcCtD
Etoposide—Vomiting—Vinorelbine—ovarian cancer	2.38e-05	0.000467	CcSEcCtD
Etoposide—Neutropenia—Epirubicin—ovarian cancer	2.37e-05	0.000465	CcSEcCtD
Etoposide—Rash—Vinorelbine—ovarian cancer	2.36e-05	0.000463	CcSEcCtD
Etoposide—Dermatitis—Vinorelbine—ovarian cancer	2.36e-05	0.000463	CcSEcCtD
Etoposide—Hypotension—Paclitaxel—ovarian cancer	2.35e-05	0.000462	CcSEcCtD
Etoposide—Headache—Vinorelbine—ovarian cancer	2.34e-05	0.00046	CcSEcCtD
Etoposide—Dysphagia—Doxorubicin—ovarian cancer	2.34e-05	0.00046	CcSEcCtD
Etoposide—Leukopenia—Docetaxel—ovarian cancer	2.34e-05	0.000459	CcSEcCtD
Etoposide—Loss of consciousness—Docetaxel—ovarian cancer	2.3e-05	0.000451	CcSEcCtD
Etoposide—Cough—Docetaxel—ovarian cancer	2.28e-05	0.000448	CcSEcCtD
Etoposide—Pneumonia—Epirubicin—ovarian cancer	2.27e-05	0.000446	CcSEcCtD
Etoposide—Convulsion—Docetaxel—ovarian cancer	2.26e-05	0.000445	CcSEcCtD
Etoposide—Paraesthesia—Paclitaxel—ovarian cancer	2.26e-05	0.000444	CcSEcCtD
Etoposide—Hypertension—Docetaxel—ovarian cancer	2.26e-05	0.000443	CcSEcCtD
Etoposide—Infestation NOS—Epirubicin—ovarian cancer	2.26e-05	0.000443	CcSEcCtD
Etoposide—Infestation—Epirubicin—ovarian cancer	2.26e-05	0.000443	CcSEcCtD
Etoposide—Dyspnoea—Paclitaxel—ovarian cancer	2.24e-05	0.000441	CcSEcCtD
Etoposide—Somnolence—Paclitaxel—ovarian cancer	2.24e-05	0.000439	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	2.24e-05	0.000439	CcSEcCtD
Etoposide—Chest pain—Docetaxel—ovarian cancer	2.22e-05	0.000437	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—ovarian cancer	2.22e-05	0.000437	CcSEcCtD
Etoposide—Nausea—Vinorelbine—ovarian cancer	2.22e-05	0.000436	CcSEcCtD
Etoposide—Renal failure—Epirubicin—ovarian cancer	2.22e-05	0.000436	CcSEcCtD
Etoposide—Neuropathy peripheral—Epirubicin—ovarian cancer	2.21e-05	0.000434	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	2.21e-05	0.000434	CcSEcCtD
Etoposide—Stomatitis—Epirubicin—ovarian cancer	2.2e-05	0.000432	CcSEcCtD
Etoposide—Jaundice—Epirubicin—ovarian cancer	2.2e-05	0.000432	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—ovarian cancer	2.19e-05	0.00043	CcSEcCtD
Etoposide—Decreased appetite—Paclitaxel—ovarian cancer	2.19e-05	0.00043	CcSEcCtD
Etoposide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	2.17e-05	0.000427	CcSEcCtD
Etoposide—Fatigue—Paclitaxel—ovarian cancer	2.17e-05	0.000426	CcSEcCtD
Etoposide—Constipation—Paclitaxel—ovarian cancer	2.15e-05	0.000423	CcSEcCtD
Etoposide—Pain—Paclitaxel—ovarian cancer	2.15e-05	0.000423	CcSEcCtD
Etoposide—Confusional state—Docetaxel—ovarian cancer	2.15e-05	0.000422	CcSEcCtD
Etoposide—Hepatobiliary disease—Epirubicin—ovarian cancer	2.13e-05	0.000419	CcSEcCtD
Etoposide—Anaphylactic shock—Docetaxel—ovarian cancer	2.13e-05	0.000419	CcSEcCtD
Etoposide—Infection—Docetaxel—ovarian cancer	2.12e-05	0.000416	CcSEcCtD
Etoposide—Agranulocytosis—Epirubicin—ovarian cancer	2.1e-05	0.000413	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—ovarian cancer	2.1e-05	0.000412	CcSEcCtD
Etoposide—Thrombocytopenia—Docetaxel—ovarian cancer	2.09e-05	0.00041	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—ovarian cancer	2.09e-05	0.00041	CcSEcCtD
Etoposide—Infestation—Doxorubicin—ovarian cancer	2.09e-05	0.00041	CcSEcCtD
Etoposide—Tachycardia—Docetaxel—ovarian cancer	2.08e-05	0.000409	CcSEcCtD
Etoposide—Feeling abnormal—Paclitaxel—ovarian cancer	2.07e-05	0.000407	CcSEcCtD
Etoposide—Skin disorder—Docetaxel—ovarian cancer	2.07e-05	0.000407	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	2.07e-05	0.000406	CcSEcCtD
Etoposide—Gastrointestinal pain—Paclitaxel—ovarian cancer	2.06e-05	0.000404	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—ovarian cancer	2.05e-05	0.000403	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—ovarian cancer	2.05e-05	0.000402	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—ovarian cancer	2.03e-05	0.0004	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—ovarian cancer	2.03e-05	0.0004	CcSEcCtD
Etoposide—Anorexia—Docetaxel—ovarian cancer	2.03e-05	0.000399	CcSEcCtD
Etoposide—Hypoaesthesia—Epirubicin—ovarian cancer	2.01e-05	0.000396	CcSEcCtD
Etoposide—Urinary tract disorder—Epirubicin—ovarian cancer	2e-05	0.000393	CcSEcCtD
Etoposide—Urticaria—Paclitaxel—ovarian cancer	2e-05	0.000393	CcSEcCtD
Etoposide—Hypotension—Docetaxel—ovarian cancer	1.99e-05	0.000391	CcSEcCtD
Etoposide—Abdominal pain—Paclitaxel—ovarian cancer	1.99e-05	0.000391	CcSEcCtD
Etoposide—Body temperature increased—Paclitaxel—ovarian cancer	1.99e-05	0.000391	CcSEcCtD
Etoposide—Urethral disorder—Epirubicin—ovarian cancer	1.98e-05	0.00039	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—ovarian cancer	1.97e-05	0.000388	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—ovarian cancer	1.95e-05	0.000383	CcSEcCtD
Etoposide—Paraesthesia—Docetaxel—ovarian cancer	1.92e-05	0.000376	CcSEcCtD
Etoposide—Erythema multiforme—Epirubicin—ovarian cancer	1.91e-05	0.000376	CcSEcCtD
Etoposide—Dyspnoea—Docetaxel—ovarian cancer	1.9e-05	0.000373	CcSEcCtD
Etoposide—Somnolence—Docetaxel—ovarian cancer	1.9e-05	0.000372	CcSEcCtD
Etoposide—Eye disorder—Epirubicin—ovarian cancer	1.89e-05	0.000372	CcSEcCtD
Etoposide—Flushing—Epirubicin—ovarian cancer	1.88e-05	0.000369	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—ovarian cancer	1.88e-05	0.000369	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—ovarian cancer	1.86e-05	0.000366	CcSEcCtD
Etoposide—Decreased appetite—Docetaxel—ovarian cancer	1.85e-05	0.000364	CcSEcCtD
Etoposide—Hypersensitivity—Paclitaxel—ovarian cancer	1.85e-05	0.000364	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—ovarian cancer	1.85e-05	0.000363	CcSEcCtD
Etoposide—Gastrointestinal disorder—Docetaxel—ovarian cancer	1.84e-05	0.000362	CcSEcCtD
Etoposide—Fatigue—Docetaxel—ovarian cancer	1.84e-05	0.000361	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—ovarian cancer	1.84e-05	0.000361	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—ovarian cancer	1.84e-05	0.000361	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—ovarian cancer	1.83e-05	0.000359	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—ovarian cancer	1.82e-05	0.000358	CcSEcCtD
Etoposide—Pain—Docetaxel—ovarian cancer	1.82e-05	0.000358	CcSEcCtD
Etoposide—Constipation—Docetaxel—ovarian cancer	1.82e-05	0.000358	CcSEcCtD
Etoposide—Chills—Epirubicin—ovarian cancer	1.82e-05	0.000357	CcSEcCtD
Etoposide—Asthenia—Paclitaxel—ovarian cancer	1.81e-05	0.000355	CcSEcCtD
Etoposide—Alopecia—Epirubicin—ovarian cancer	1.79e-05	0.000351	CcSEcCtD
Etoposide—Pruritus—Paclitaxel—ovarian cancer	1.78e-05	0.00035	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—ovarian cancer	1.77e-05	0.000348	CcSEcCtD
Etoposide—Feeling abnormal—Docetaxel—ovarian cancer	1.76e-05	0.000345	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—ovarian cancer	1.75e-05	0.000344	CcSEcCtD
Etoposide—Gastrointestinal pain—Docetaxel—ovarian cancer	1.74e-05	0.000343	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—ovarian cancer	1.74e-05	0.000342	CcSEcCtD
Etoposide—Flushing—Doxorubicin—ovarian cancer	1.74e-05	0.000342	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—ovarian cancer	1.73e-05	0.000339	CcSEcCtD
Etoposide—Diarrhoea—Paclitaxel—ovarian cancer	1.72e-05	0.000338	CcSEcCtD
Etoposide—Back pain—Epirubicin—ovarian cancer	1.7e-05	0.000335	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—ovarian cancer	1.7e-05	0.000334	CcSEcCtD
Etoposide—Muscle spasms—Epirubicin—ovarian cancer	1.69e-05	0.000333	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—ovarian cancer	1.69e-05	0.000332	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—ovarian cancer	1.69e-05	0.000332	CcSEcCtD
Etoposide—Body temperature increased—Docetaxel—ovarian cancer	1.69e-05	0.000331	CcSEcCtD
Etoposide—Abdominal pain—Docetaxel—ovarian cancer	1.69e-05	0.000331	CcSEcCtD
Etoposide—Chills—Doxorubicin—ovarian cancer	1.68e-05	0.00033	CcSEcCtD
Etoposide—Dizziness—Paclitaxel—ovarian cancer	1.66e-05	0.000327	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—ovarian cancer	1.66e-05	0.000325	CcSEcCtD
Etoposide—Ill-defined disorder—Epirubicin—ovarian cancer	1.64e-05	0.000321	CcSEcCtD
Etoposide—Anaemia—Epirubicin—ovarian cancer	1.63e-05	0.00032	CcSEcCtD
Etoposide—Vomiting—Paclitaxel—ovarian cancer	1.6e-05	0.000314	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—ovarian cancer	1.6e-05	0.000314	CcSEcCtD
Etoposide—Malaise—Epirubicin—ovarian cancer	1.59e-05	0.000312	CcSEcCtD
Etoposide—Rash—Paclitaxel—ovarian cancer	1.59e-05	0.000312	CcSEcCtD
Etoposide—Dermatitis—Paclitaxel—ovarian cancer	1.59e-05	0.000311	CcSEcCtD
Etoposide—Vertigo—Epirubicin—ovarian cancer	1.58e-05	0.000311	CcSEcCtD
Etoposide—Leukopenia—Epirubicin—ovarian cancer	1.58e-05	0.00031	CcSEcCtD
Etoposide—Back pain—Doxorubicin—ovarian cancer	1.58e-05	0.00031	CcSEcCtD
Etoposide—Headache—Paclitaxel—ovarian cancer	1.58e-05	0.00031	CcSEcCtD
Etoposide—Hypersensitivity—Docetaxel—ovarian cancer	1.57e-05	0.000309	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—ovarian cancer	1.57e-05	0.000308	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—ovarian cancer	1.55e-05	0.000304	CcSEcCtD
Etoposide—Cough—Epirubicin—ovarian cancer	1.54e-05	0.000302	CcSEcCtD
Etoposide—Asthenia—Docetaxel—ovarian cancer	1.53e-05	0.000301	CcSEcCtD
Etoposide—Convulsion—Epirubicin—ovarian cancer	1.53e-05	0.0003	CcSEcCtD
Etoposide—Hypertension—Epirubicin—ovarian cancer	1.52e-05	0.000299	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—ovarian cancer	1.51e-05	0.000297	CcSEcCtD
Etoposide—Pruritus—Docetaxel—ovarian cancer	1.51e-05	0.000296	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—ovarian cancer	1.51e-05	0.000296	CcSEcCtD
Etoposide—Chest pain—Epirubicin—ovarian cancer	1.5e-05	0.000295	CcSEcCtD
Etoposide—Nausea—Paclitaxel—ovarian cancer	1.49e-05	0.000294	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	1.49e-05	0.000293	CcSEcCtD
Etoposide—Discomfort—Epirubicin—ovarian cancer	1.48e-05	0.000291	CcSEcCtD
Etoposide—Malaise—Doxorubicin—ovarian cancer	1.47e-05	0.000289	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—ovarian cancer	1.47e-05	0.000288	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—ovarian cancer	1.46e-05	0.000287	CcSEcCtD
Etoposide—Diarrhoea—Docetaxel—ovarian cancer	1.46e-05	0.000287	CcSEcCtD
Etoposide—Confusional state—Epirubicin—ovarian cancer	1.45e-05	0.000285	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—ovarian cancer	1.44e-05	0.000283	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—ovarian cancer	1.43e-05	0.000282	CcSEcCtD
Etoposide—Infection—Epirubicin—ovarian cancer	1.43e-05	0.000281	CcSEcCtD
Etoposide—Cough—Doxorubicin—ovarian cancer	1.42e-05	0.00028	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—ovarian cancer	1.41e-05	0.000278	CcSEcCtD
Etoposide—Dizziness—Docetaxel—ovarian cancer	1.41e-05	0.000277	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—ovarian cancer	1.41e-05	0.000277	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—ovarian cancer	1.41e-05	0.000277	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—ovarian cancer	1.4e-05	0.000276	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—ovarian cancer	1.4e-05	0.000274	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—ovarian cancer	1.39e-05	0.000273	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—ovarian cancer	1.39e-05	0.000273	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	1.38e-05	0.000271	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—ovarian cancer	1.37e-05	0.000269	CcSEcCtD
Etoposide—Anorexia—Epirubicin—ovarian cancer	1.37e-05	0.000269	CcSEcCtD
Etoposide—Vomiting—Docetaxel—ovarian cancer	1.36e-05	0.000266	CcSEcCtD
Etoposide—Rash—Docetaxel—ovarian cancer	1.34e-05	0.000264	CcSEcCtD
Etoposide—Hypotension—Epirubicin—ovarian cancer	1.34e-05	0.000264	CcSEcCtD
Etoposide—Dermatitis—Docetaxel—ovarian cancer	1.34e-05	0.000264	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—ovarian cancer	1.34e-05	0.000264	CcSEcCtD
Etoposide—Headache—Docetaxel—ovarian cancer	1.34e-05	0.000262	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—ovarian cancer	1.33e-05	0.000261	CcSEcCtD
Etoposide—Infection—Doxorubicin—ovarian cancer	1.32e-05	0.00026	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—ovarian cancer	1.3e-05	0.000256	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—ovarian cancer	1.3e-05	0.000255	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—ovarian cancer	1.29e-05	0.000254	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—ovarian cancer	1.29e-05	0.000254	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—ovarian cancer	1.29e-05	0.000253	CcSEcCtD
Etoposide—Dyspnoea—Epirubicin—ovarian cancer	1.28e-05	0.000252	CcSEcCtD
Etoposide—Somnolence—Epirubicin—ovarian cancer	1.28e-05	0.000251	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—ovarian cancer	1.27e-05	0.000249	CcSEcCtD
Etoposide—Nausea—Docetaxel—ovarian cancer	1.27e-05	0.000249	CcSEcCtD
Etoposide—Decreased appetite—Epirubicin—ovarian cancer	1.25e-05	0.000246	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—ovarian cancer	1.24e-05	0.000244	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.24e-05	0.000244	CcSEcCtD
Etoposide—Fatigue—Epirubicin—ovarian cancer	1.24e-05	0.000244	CcSEcCtD
Etoposide—Pain—Epirubicin—ovarian cancer	1.23e-05	0.000242	CcSEcCtD
Etoposide—Constipation—Epirubicin—ovarian cancer	1.23e-05	0.000242	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—ovarian cancer	1.2e-05	0.000235	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—ovarian cancer	1.19e-05	0.000233	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—ovarian cancer	1.19e-05	0.000233	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—ovarian cancer	1.18e-05	0.000232	CcSEcCtD
Etoposide—Gastrointestinal pain—Epirubicin—ovarian cancer	1.18e-05	0.000231	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—ovarian cancer	1.16e-05	0.000227	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.15e-05	0.000226	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—ovarian cancer	1.15e-05	0.000225	CcSEcCtD
Etoposide—Urticaria—Epirubicin—ovarian cancer	1.14e-05	0.000224	CcSEcCtD
Etoposide—Constipation—Doxorubicin—ovarian cancer	1.14e-05	0.000224	CcSEcCtD
Etoposide—Pain—Doxorubicin—ovarian cancer	1.14e-05	0.000224	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—ovarian cancer	1.14e-05	0.000223	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—ovarian cancer	1.14e-05	0.000223	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—ovarian cancer	1.1e-05	0.000215	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—ovarian cancer	1.09e-05	0.000214	CcSEcCtD
Etoposide—Hypersensitivity—Epirubicin—ovarian cancer	1.06e-05	0.000208	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—ovarian cancer	1.06e-05	0.000208	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—ovarian cancer	1.05e-05	0.000207	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—ovarian cancer	1.05e-05	0.000207	CcSEcCtD
Etoposide—Asthenia—Epirubicin—ovarian cancer	1.03e-05	0.000203	CcSEcCtD
Etoposide—Pruritus—Epirubicin—ovarian cancer	1.02e-05	0.0002	CcSEcCtD
Etoposide—Diarrhoea—Epirubicin—ovarian cancer	9.84e-06	0.000193	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—ovarian cancer	9.81e-06	0.000193	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—ovarian cancer	9.55e-06	0.000188	CcSEcCtD
Etoposide—Dizziness—Epirubicin—ovarian cancer	9.51e-06	0.000187	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—ovarian cancer	9.42e-06	0.000185	CcSEcCtD
Etoposide—Vomiting—Epirubicin—ovarian cancer	9.15e-06	0.00018	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—ovarian cancer	9.11e-06	0.000179	CcSEcCtD
Etoposide—Rash—Epirubicin—ovarian cancer	9.07e-06	0.000178	CcSEcCtD
Etoposide—Dermatitis—Epirubicin—ovarian cancer	9.06e-06	0.000178	CcSEcCtD
Etoposide—Headache—Epirubicin—ovarian cancer	9.01e-06	0.000177	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—ovarian cancer	8.8e-06	0.000173	CcSEcCtD
Etoposide—Nausea—Epirubicin—ovarian cancer	8.54e-06	0.000168	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—ovarian cancer	8.46e-06	0.000166	CcSEcCtD
Etoposide—Rash—Doxorubicin—ovarian cancer	8.39e-06	0.000165	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—ovarian cancer	8.38e-06	0.000165	CcSEcCtD
Etoposide—Headache—Doxorubicin—ovarian cancer	8.34e-06	0.000164	CcSEcCtD
Etoposide—Nausea—Doxorubicin—ovarian cancer	7.91e-06	0.000155	CcSEcCtD
Etoposide—PTGS1—Metabolism—FASN—ovarian cancer	2.8e-06	0.000228	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PPP2R1A—ovarian cancer	2.78e-06	0.000226	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—SLC2A1—ovarian cancer	2.77e-06	0.000225	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—SLC5A5—ovarian cancer	2.76e-06	0.000224	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.74e-06	0.000223	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—YAP1—ovarian cancer	2.73e-06	0.000222	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—ovarian cancer	2.73e-06	0.000221	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.7e-06	0.00022	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PPP2R1A—ovarian cancer	2.68e-06	0.000218	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.67e-06	0.000217	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—SLC2A1—ovarian cancer	2.66e-06	0.000216	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP1B1—ovarian cancer	2.66e-06	0.000216	CbGpPWpGaD
Etoposide—PTGS2—Disease—FASN—ovarian cancer	2.66e-06	0.000216	CbGpPWpGaD
Etoposide—PTGS2—Disease—PARP1—ovarian cancer	2.65e-06	0.000215	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYTB—ovarian cancer	2.64e-06	0.000214	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.61e-06	0.000212	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.6e-06	0.000211	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ABCB1—ovarian cancer	2.58e-06	0.00021	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—AKT1—ovarian cancer	2.58e-06	0.00021	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.58e-06	0.000209	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—YAP1—ovarian cancer	2.57e-06	0.000209	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—YAP1—ovarian cancer	2.57e-06	0.000208	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP1B1—ovarian cancer	2.55e-06	0.000207	CbGpPWpGaD
Etoposide—ABCC1—Disease—TERT—ovarian cancer	2.54e-06	0.000206	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—TYMS—ovarian cancer	2.53e-06	0.000206	CbGpPWpGaD
Etoposide—PTGS2—Disease—SLC2A1—ovarian cancer	2.53e-06	0.000205	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.53e-06	0.000205	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CAV1—ovarian cancer	2.51e-06	0.000204	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ABCB1—ovarian cancer	2.49e-06	0.000202	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.47e-06	0.000201	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.47e-06	0.000201	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.47e-06	0.000201	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTEN—ovarian cancer	2.45e-06	0.000199	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—TYMS—ovarian cancer	2.44e-06	0.000198	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.41e-06	0.000196	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.4e-06	0.000195	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.38e-06	0.000193	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PPP2R1A—ovarian cancer	2.36e-06	0.000192	CbGpPWpGaD
Etoposide—ABCC1—Disease—CAV1—ovarian cancer	2.35e-06	0.000191	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.33e-06	0.000189	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—BRIP1—ovarian cancer	2.3e-06	0.000187	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPP1CC—ovarian cancer	2.3e-06	0.000187	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CG—ovarian cancer	2.29e-06	0.000186	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPP2R1A—ovarian cancer	2.27e-06	0.000184	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.25e-06	0.000183	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6ST—ovarian cancer	2.23e-06	0.000181	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—FASN—ovarian cancer	2.23e-06	0.000181	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—YAP1—ovarian cancer	2.22e-06	0.000181	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.2e-06	0.000179	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SLC5A5—ovarian cancer	2.19e-06	0.000178	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ABCB1—ovarian cancer	2.19e-06	0.000178	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—TYMS—ovarian cancer	2.15e-06	0.000175	CbGpPWpGaD
Etoposide—PTGS2—Disease—PPP2R1A—ovarian cancer	2.15e-06	0.000174	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.14e-06	0.000174	CbGpPWpGaD
Etoposide—ABCC1—Disease—APC—ovarian cancer	2.14e-06	0.000174	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SLC2A1—ovarian cancer	2.12e-06	0.000172	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ABCB1—ovarian cancer	2.1e-06	0.000171	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—FASN—ovarian cancer	2.1e-06	0.00017	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—FASN—ovarian cancer	2.09e-06	0.00017	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.07e-06	0.000168	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.07e-06	0.000168	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—TYMS—ovarian cancer	2.07e-06	0.000168	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SLC5A5—ovarian cancer	2.06e-06	0.000167	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SLC5A5—ovarian cancer	2.06e-06	0.000167	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CAV1—ovarian cancer	2.04e-06	0.000166	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYTB—ovarian cancer	2.03e-06	0.000165	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP1B1—ovarian cancer	2.03e-06	0.000165	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CD—ovarian cancer	2.01e-06	0.000163	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.99e-06	0.000162	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.99e-06	0.000161	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CAV1—ovarian cancer	1.97e-06	0.00016	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—YAP1—ovarian cancer	1.94e-06	0.000157	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.93e-06	0.000157	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.91e-06	0.000155	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.91e-06	0.000155	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CD—ovarian cancer	1.88e-06	0.000153	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.88e-06	0.000153	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CG—ovarian cancer	1.86e-06	0.000151	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—FASN—ovarian cancer	1.81e-06	0.000147	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPP2R1A—ovarian cancer	1.8e-06	0.000146	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CG—ovarian cancer	1.79e-06	0.000146	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.79e-06	0.000145	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.78e-06	0.000145	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.78e-06	0.000144	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.78e-06	0.000144	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CB—ovarian cancer	1.75e-06	0.000142	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.75e-06	0.000142	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CAV1—ovarian cancer	1.73e-06	0.000141	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PIK3CA—ovarian cancer	1.73e-06	0.000141	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.72e-06	0.00014	CbGpPWpGaD
Etoposide—PTGS2—Disease—TERT—ovarian cancer	1.71e-06	0.000139	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.69e-06	0.000138	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.69e-06	0.000137	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.69e-06	0.000137	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.68e-06	0.000136	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ABCB1—ovarian cancer	1.67e-06	0.000136	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CAV1—ovarian cancer	1.66e-06	0.000135	CbGpPWpGaD
Etoposide—ABCC1—Disease—ERBB2—ovarian cancer	1.66e-06	0.000135	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.65e-06	0.000134	CbGpPWpGaD
Etoposide—ABCC1—Disease—MTOR—ovarian cancer	1.64e-06	0.000133	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CB—ovarian cancer	1.64e-06	0.000133	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—TYMS—ovarian cancer	1.64e-06	0.000133	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CD—ovarian cancer	1.64e-06	0.000133	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.59e-06	0.000129	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—FASN—ovarian cancer	1.58e-06	0.000128	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CG—ovarian cancer	1.58e-06	0.000128	CbGpPWpGaD
Etoposide—PTGS2—Disease—CAV1—ovarian cancer	1.58e-06	0.000128	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CD—ovarian cancer	1.58e-06	0.000128	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ABCB1—ovarian cancer	1.57e-06	0.000128	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ABCB1—ovarian cancer	1.57e-06	0.000127	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.55e-06	0.000126	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—YAP1—ovarian cancer	1.55e-06	0.000126	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—TYMS—ovarian cancer	1.54e-06	0.000125	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—TYMS—ovarian cancer	1.54e-06	0.000125	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1B—ovarian cancer	1.54e-06	0.000125	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.53e-06	0.000124	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.52e-06	0.000123	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTEN—ovarian cancer	1.52e-06	0.000123	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.5e-06	0.000122	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6ST—ovarian cancer	1.5e-06	0.000122	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.46e-06	0.000119	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.46e-06	0.000118	CbGpPWpGaD
Etoposide—ABCC1—Disease—CTNNB1—ovarian cancer	1.46e-06	0.000118	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1B1—ovarian cancer	1.44e-06	0.000117	CbGpPWpGaD
Etoposide—PTGS2—Disease—APC—ovarian cancer	1.44e-06	0.000117	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CB—ovarian cancer	1.43e-06	0.000116	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—ovarian cancer	1.42e-06	0.000115	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—ovarian cancer	1.41e-06	0.000115	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CD—ovarian cancer	1.39e-06	0.000113	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CB—ovarian cancer	1.37e-06	0.000112	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.36e-06	0.00011	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.34e-06	0.000109	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TYMS—ovarian cancer	1.33e-06	0.000108	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CD—ovarian cancer	1.33e-06	0.000108	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CAV1—ovarian cancer	1.32e-06	0.000107	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPP2R1A—ovarian cancer	1.28e-06	0.000104	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—ovarian cancer	1.27e-06	0.000103	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRAS—ovarian cancer	1.27e-06	0.000103	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CD—ovarian cancer	1.26e-06	0.000103	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.26e-06	0.000103	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—FASN—ovarian cancer	1.26e-06	0.000102	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CAV1—ovarian cancer	1.24e-06	0.000101	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CAV1—ovarian cancer	1.24e-06	0.000101	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.24e-06	0.000101	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—ovarian cancer	1.23e-06	0.0001	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK3—ovarian cancer	1.21e-06	9.84e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CB—ovarian cancer	1.21e-06	9.82e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CG—ovarian cancer	1.2e-06	9.78e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.2e-06	9.72e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—YAP1—ovarian cancer	1.19e-06	9.69e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—ovarian cancer	1.19e-06	9.65e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—ovarian cancer	1.18e-06	9.57e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.17e-06	9.52e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TYMS—ovarian cancer	1.16e-06	9.44e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CB—ovarian cancer	1.16e-06	9.44e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK1—ovarian cancer	1.15e-06	9.36e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—ovarian cancer	1.15e-06	9.36e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.15e-06	9.32e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CG—ovarian cancer	1.13e-06	9.2e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CG—ovarian cancer	1.13e-06	9.19e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB2—ovarian cancer	1.12e-06	9.07e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CB—ovarian cancer	1.1e-06	8.95e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MTOR—ovarian cancer	1.1e-06	8.95e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—ovarian cancer	1.09e-06	8.84e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CAV1—ovarian cancer	1.08e-06	8.73e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—ovarian cancer	1.07e-06	8.68e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CD—ovarian cancer	1.06e-06	8.6e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—ovarian cancer	1.05e-06	8.49e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1B—ovarian cancer	1.03e-06	8.4e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.03e-06	8.34e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.02e-06	8.27e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.01e-06	8.23e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—ovarian cancer	1e-06	8.16e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—ovarian cancer	1e-06	8.13e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CD—ovarian cancer	9.96e-07	8.09e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CD—ovarian cancer	9.94e-07	8.07e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CG—ovarian cancer	9.8e-07	7.96e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CTNNB1—ovarian cancer	9.77e-07	7.93e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—FASN—ovarian cancer	9.73e-07	7.9e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC5A5—ovarian cancer	9.57e-07	7.77e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—ovarian cancer	9.52e-07	7.73e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCB1—ovarian cancer	9.45e-07	7.68e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CAV1—ovarian cancer	9.37e-07	7.61e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TYMS—ovarian cancer	9.28e-07	7.54e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—ovarian cancer	9.26e-07	7.52e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC2A1—ovarian cancer	9.24e-07	7.5e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CB—ovarian cancer	9.22e-07	7.49e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—ovarian cancer	8.86e-07	7.2e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1B1—ovarian cancer	8.86e-07	7.19e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—ovarian cancer	8.74e-07	7.09e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—ovarian cancer	8.69e-07	7.06e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CB—ovarian cancer	8.68e-07	7.05e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CB—ovarian cancer	8.67e-07	7.04e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CD—ovarian cancer	8.61e-07	6.99e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CG—ovarian cancer	8.53e-07	6.93e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—ovarian cancer	8.51e-07	6.91e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRAS—ovarian cancer	8.49e-07	6.9e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—ovarian cancer	8.38e-07	6.81e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—ovarian cancer	8.17e-07	6.64e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK3—ovarian cancer	8.13e-07	6.61e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—ovarian cancer	7.97e-07	6.47e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—ovarian cancer	7.91e-07	6.42e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	7.86e-07	6.38e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK1—ovarian cancer	7.74e-07	6.28e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—ovarian cancer	7.74e-07	6.28e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CB—ovarian cancer	7.51e-07	6.1e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—ovarian cancer	7.5e-07	6.09e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CD—ovarian cancer	7.5e-07	6.09e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—ovarian cancer	7.49e-07	6.08e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CAV1—ovarian cancer	7.48e-07	6.07e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—ovarian cancer	7.37e-07	5.99e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—ovarian cancer	7.31e-07	5.94e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCB1—ovarian cancer	7.29e-07	5.92e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TYMS—ovarian cancer	7.16e-07	5.82e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.15e-07	5.8e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—ovarian cancer	7.1e-07	5.77e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—ovarian cancer	7.08e-07	5.75e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—ovarian cancer	6.85e-07	5.56e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CG—ovarian cancer	6.81e-07	5.53e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—ovarian cancer	6.71e-07	5.45e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CB—ovarian cancer	6.54e-07	5.31e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—ovarian cancer	6.49e-07	5.27e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—ovarian cancer	6.21e-07	5.05e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—ovarian cancer	6.02e-07	4.89e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CD—ovarian cancer	5.99e-07	4.86e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—ovarian cancer	5.95e-07	4.83e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—ovarian cancer	5.79e-07	4.7e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CAV1—ovarian cancer	5.77e-07	4.69e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—ovarian cancer	5.65e-07	4.59e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—ovarian cancer	5.62e-07	4.57e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—ovarian cancer	5.49e-07	4.46e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—ovarian cancer	5.29e-07	4.3e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—ovarian cancer	5.28e-07	4.29e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5.26e-07	4.27e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CB—ovarian cancer	5.22e-07	4.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CD—ovarian cancer	4.62e-07	3.75e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—ovarian cancer	4.59e-07	3.73e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—ovarian cancer	4.58e-07	3.72e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—ovarian cancer	4.51e-07	3.66e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—ovarian cancer	4.32e-07	3.51e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—ovarian cancer	4.32e-07	3.5e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.03e-07	3.27e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—ovarian cancer	3.99e-07	3.24e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—ovarian cancer	3.74e-07	3.04e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—ovarian cancer	3.48e-07	2.83e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—ovarian cancer	3.26e-07	2.64e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—ovarian cancer	3.18e-07	2.58e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—ovarian cancer	2.6e-07	2.11e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.46e-07	1.99e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—ovarian cancer	2.01e-07	1.63e-05	CbGpPWpGaD
